Till innehåll på sidan
Till KTH:s startsida

Publikationer

Institutionens 50 senaste publikationer

[1]
Pacia, D. M., Ravitsky, V., Hansen, J. N., Käller Lundberg, E., Schulz, W. & Belisle-Pipon, J.-C. (2024). Early AI Lifecycle Co-Reasoning : Ethics Through Integrated and Diverse Team Science. American Journal of Bioethics, 24(9), 86-88.
[2]
Baudin, J., Hernandez-Baixauli, J., Romero-Giménez, J., Yang, H., Mulero, F., Puiggròs, F. ... Caimari, A. (2024). A cocktail of histidine, carnosine, cysteine and serine reduces adiposity and improves metabolic health and adipose tissue immunometabolic function in ovariectomized rats. Biomedicine and Pharmacotherapy, 179.
[4]
Ek, M., Nilvebrant, J., Nygren, P.-Å., Ståhl, S., Lindberg, H. & Löfblom, J. (2024). An anti-sortilin affibody-peptide fusion inhibits sortilin-mediated progranulin degradation. Frontiers in Immunology, 15.
[5]
Halama, A., Zaghlool, S., Thareja, G., Kader, S., Al Muftah, W., Mook-Kanamori, M. ... Suhre, K. (2024). A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes. Nature Communications, 15(1).
[8]
Nagy, A. (2024). Bioconjugation of antibodies and affinity proteins for the development of novel diagnostic and therapeutic tools (Doktorsavhandling , KTH Royal Institute of Technology, TRITA-CBH-FOU 2024:29). Hämtad från https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-351396.
[9]
Kaynar, A., Ozcan, M., Li, X., Turkez, H., Zhang, C., Uhlén, M. ... Mardinoglu, A. (2024). Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach. International Journal of Molecular Sciences, 25(14).
[10]
Iqbal, S., Islam, M. Z., Ashraf, S., Kim, W., AL-Sharabi, A. A., Ozcan, M. ... Mardinoglu, A. (2024). Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins. International Journal of Molecular Sciences, 25(14).
[14]
[15]
[16]
Bouzian, Y., El Hafi, M., Parvizi, N., Kim, W., Subaşioğlu, M., Ozcan, M. ... Mardinoglu, A. (2024). Design and evaluation of novel inhibitors for the treatment of clear cell renal cell carcinoma. Bioorganic chemistry, 151.
[17]
Mamand, D. R., Bazaz, S., Mohammad, D. K., Liang, X., Pavlova, S., Mim, C. ... EL-Andaloussi, S. (2024). Extracellular vesicles originating from melanoma cells promote dysregulation in haematopoiesis as a component of cancer immunoediting. Journal of Extracellular Vesicles, 13(7).
[18]
Urrutia Iturritza, M., Mlotshwa, P., Gantelius, J., Alfven, T., Loh, E., Karlsson, J. ... Gaudenzi, G. (2024). An Automated Versatile Diagnostic Workflow for Infectious Disease Detection in Low-Resource Settings. Micromachines, 15(6).
[19]
Raja, S. N., Jain, S., Kipen, J., Jaldén, J., Stemme, G., Herland, A. & Niklaus, F. (2024). Electromigrated Gold Nanogap Tunnel Junction Arrays: Fabrication and Electrical Behavior in Liquid and Gaseous Media. ACS Applied Materials and Interfaces.
[20]
Habibey, R., Striebel, J., Meinert, M., Latiftikhereshki, R., Schmieder, F., Nasiri, R. & Latifi, S. (2024). Engineered modular neuronal networks-on-chip represent structure-function relationship. Biosensors & bioelectronics, 261.
[21]
Tanriverdi, S., Cruz, J., Habibi, S., Amini, K., Costa, M., Lundell, F. ... Russom, A. (2024). Elasto-inertial focusing and particle migration in high aspect ratio microchannels for high-throughput separation. Microsystems and Nanoengineering, 10(1).
[30]
Dannemeyer, M., Berling, A., Kanje, S., Enstedt, H., Xu, L., Afshari, D. ... Tegel, H. (2024). Fast and robust recombinant protein production utilizing episomal stable pools in WAVE bioreactors. Protein Expression and Purification, 221.
[32]
Chang, Y. C., Gnann, C., Steimbach, R. R., Bayer, F. P., Lechner, S., Sakhteman, A. ... Kuster, B. (2024). Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics. Cell Reports, 43(6).
[33]
Monteiro, F. L., Stepanauskaite, L., Archer, A. & Williams, C. (2024). Estrogen receptor beta expression and role in cancers. Journal of Steroid Biochemistry and Molecular Biology, 242.
[34]
Iqbal, S., Sebhaoui, J., Ashraf, S., Özcan, M., Kim, W., Belmen, B. ... Mardinoglu, A. (2024). Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma. Bioorganic chemistry, 147.
[35]
Bragina, O., Tashireva, L., Loos, D., Chernov, V., Hober, S. & Tolmachev, V. (2024). Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [<sup>99m</sup>Tc]Tc-ADAPT6. Pharmaceutics, 16(4).
[36]
Altay, Ö., Yang, H., Yildirim, S., Bayram, C., Bolat, I., Oner, S. ... Mardinoglu, A. (2024). Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases. Biomedicines, 12(4).
[37]
Parks, L. (2024). Development of directed-evolution methods utilizing combinatorial protein libraries in Escherichia coli (Doktorsavhandling , KTH Royal Institute of Technology, Stockholm, TRITA-CBH-FOU 2024:10). Hämtad från https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-346195.
[38]
Mohammadi, E., Dashti, S., Shafizade, N., Jin, H., Zhang, C., Lam, S. ... Sekhavati, M. H. (2024). Drug repositioning for immunotherapy in breast cancer using single-cell analysis. npj Systems Biology and Applications, 10(1).
[39]
Klevebro, S., Kebede Merid, S., Sjöbom, U., Zhong, W., Danielsson, H., Wackernagel, D. ... Nilsson, A. K. (2024). Arachidonic acid and docosahexaenoic acid levels correlate with the inflammation proteome in extremely preterm infants. Clinical Nutrition, 43(5), 1162-1170.
[40]
Yan, J., Bangalore, C. R., Nikouyan, N., Appelberg, S., Silva, D. N., Yao, H. ... Saellberg, M. (2024). Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease. Molecular Therapy, 32(2), 540-555.
[41]
Bonanini, F., Singh, M., Yang, H., Kurek, D., Harms, A. C., Mardinoglu, A. & Hankemeier, T. (2024). A comparison between different human hepatocyte models reveals profound differences in net glucose production, lipid composition and metabolism in vitro. Experimental Cell Research, 437(1).
[42]
Charras, Q., Rey, P., Guillemain, D., Dourguin, F., Laganier, H., Peschoux, S. ... Jungas, C. (2024). An efficient protocol for extracting thylakoid membranes and total leaf proteins from Posidonia oceanica and other polyphenol-rich plants. Plant Methods, 20(1).
[43]
Michalettou, T. D., Hong, M.-G., Fernandez, J., Sharma, S., Brorsson, C., Koivula, R. ... Vinuela, A. (2024). Dissecting the interplay between ageing, sex and body mass index on a molecular level. European Journal of Human Genetics, 32, 656-657.
[45]
Öling, S., Struck, E., Noreen-Thorsen, M., Zwahlen, M., von Feilitzen, K., Odeberg, J. ... Butler, L. M. (2024). A human stomach cell type transcriptome atlas. BMC Biology, 22(1).
[46]
Mravinacová, S., Alanko, V., Bergström, S., Bridel, C., Pijnenburg, Y., Hagman, G. ... Månberg, A. (2024). CSF protein ratios with enhanced potential to reflect Alzheimer’s disease pathology and neurodegeneration. Molecular Neurodegeneration, 19(1).
[47]
Turkez, H., Arslan, M. E., Selvitopi, H., Kadi, A., Oner, S. & Mardinoglu, A. (2024). Drug Synergism of Anticancer Action in Combination with Favipiravir and Paclitaxel on Neuroblastoma Cells. Medicina, 60(1).
[48]
Enrico, A., Buchmann, S., De Ferrari, F., Lin, Y., Wang, Y., Yue, W. ... Zeglio, E. (2024). Cleanroom‐Free Direct Laser Micropatterning of Polymers for Organic Electrochemical Transistors in Logic Circuits and Glucose Biosensors. Advanced Science.
[49]
Mebrahtu, A., Aniander, G., Mega, A., Moradi, M., Thalén, N., Gudmundsdotter, L. ... Rockberg, J. (2024). Co-culture platform for tuning of cancer receptor density allows for evaluation of bispecific immune cell engagers. New Biotechnology, 79, 120-126.
[50]
Gouleni, N., Di Rienzo, A., Oner, S., Karagoz, C., Arslan, M. E., Mardinoglu, A. ... Cacciatore, I. (2024). Anticancer Potential of Novel Cinnamoyl Derivatives against U87MG and SHSY-5Y Cell Lines. Anti-Cancer Agents in Medicinal Chemistry, 24(1), 39-49.